Eric Heil

Eric Heil is an accomplished executive with extensive leadership experience in the medical and therapeutic sectors. Currently serving as the Chief Commercial Officer at Osteal Therapeutics, Eric has previously held the position of Chief Executive Officer at USA Therm, Inc. and has significantly contributed to Boston Scientific as a Global Leader in Strategy and Therapy Advancement, as well as leading the Varithena brand for superficial venous treatments. Prior roles include Vice President and General Manager of US Commercial at BTG plc, Vice President of Sales and Marketing, and Vice President of U.S. Sales at Novasys Medical, which was later acquired by Verathon Medical. Eric Heil holds a Bachelor of Arts degree in Political Science and Government Affairs from the University of North Texas.